Influenza Antivirals: Efficacy and Resistance
Tuesday 8th - Thursday 10th November 2011
Rio Othon Palace Hotel, Rio de Janeiro, Brazil

We are delighted to announce that the inaugural conference of the isirv-Antiviral Group (isirv-AVG) will take place in Rio de Janeiro (Copacabana Beach), Brazil from 8th -10th November 2011 and is organised in conjunction with the Oswaldo Cruz Foundation (Fiocruz) and PAHO. Sprawling across half of South America, Brazil has captivated travellers for 500 years. Rio is a very vibrant city with Copacabana being the most famous region of the south zone of Rio.

The emergent 2009 H1N1 pandemic brought into acute focus the uses and limitations of the available anti-influenza drugs in mitigating the early impact of an influenza pandemic. Specific topics to be covered in the programme include: the available anti-influenza drugs and their use in different situations and settings; the emergence and molecular basis of resistance; surveillance and detection of resistant phenotypes and resistance mutations, especially in relation to drug use; associated studies of potential local and community spread; animal studies of virus fitness and the potential clinical/epidemiological significance of resistant mutants; new antiviral approaches and drug combinations.

From April 2011, visit the isirv-AVG (formerly NISN www.nisn.org ) website for details on the preliminary programme; further details on hotel accommodation, abstract submission etc will be available soon after. If you have any questions, please do not hesitate to contact the isirv-AVG Conference Organiser Lida DeSouza on +44 1252 722185 or by email at isirv-AVG@desouza-associates.com.